Clinical Trial: Real-World Validation of Huawei Wearable Technologies for Hypertension Risk Screening in Malaysia

U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07785895) titled 'Real-World Validation of Huawei Wearable Technologies for Hypertension Risk Screening in Malaysia' on Aug. 18.

Brief Summary: Background:

Hypertension (high blood pressure) is a major risk factor for heart disease and stroke, yet many people do not know they have it. In Malaysia, nearly half of all adults with elevated blood pressure are unaware of their condition. Standard clinic blood pressure checks can miss cases of high blood pressure or falsely flag temporary stress-related spikes. While 24-hour Ambulatory Blood Pressure Monitoring (ABPM) is the standard method for an accurate diagnosis, it is not practical for large-scale sc...